LONARDI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.798
AS - Asia 825
EU - Europa 520
SA - Sud America 166
AF - Africa 60
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.375
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.773
SG - Singapore 326
CN - Cina 235
HK - Hong Kong 189
BR - Brasile 147
DE - Germania 138
IT - Italia 83
FI - Finlandia 51
FR - Francia 39
GB - Regno Unito 38
CI - Costa d'Avorio 31
NL - Olanda 27
RU - Federazione Russa 26
AT - Austria 20
PL - Polonia 20
SE - Svezia 19
UA - Ucraina 16
IN - India 13
BD - Bangladesh 8
CA - Canada 8
HU - Ungheria 8
TR - Turchia 8
ZA - Sudafrica 7
ES - Italia 6
IQ - Iraq 6
VN - Vietnam 6
AR - Argentina 5
VE - Venezuela 5
MX - Messico 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
LV - Lettonia 3
MD - Moldavia 3
PH - Filippine 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
AZ - Azerbaigian 2
CD - Congo 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
IR - Iran 2
JP - Giappone 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MA - Marocco 2
MK - Macedonia 2
NC - Nuova Caledonia 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
EC - Ecuador 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GN - Guinea 1
GR - Grecia 1
HT - Haiti 1
JM - Giamaica 1
KR - Corea 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LY - Libia 1
MG - Madagascar 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PF - Polinesia Francese 1
PY - Paraguay 1
SA - Arabia Saudita 1
TG - Togo 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 4.373
Salva come PNG Salva come JPEG
Città #
Fairfield 454
Chandler 328
Ashburn 202
Singapore 199
Hong Kong 188
Seattle 187
Woodbridge 173
Cambridge 171
Houston 161
Ann Arbor 125
Wilmington 120
Santa Clara 79
Boardman 62
Beijing 55
Munich 51
San Diego 47
Medford 41
Princeton 41
Helsinki 37
Abidjan 31
Des Moines 26
Padova 24
Guangzhou 20
Bytom 18
Los Angeles 17
Nuremberg 16
Roxbury 16
São Paulo 15
Jacksonville 12
London 11
New York 11
Turku 10
Chicago 9
Dallas 9
Düsseldorf 9
Vienna 9
Lauterbourg 8
Nanjing 8
Brooklyn 7
Budapest 7
Falkenstein 7
Nanchang 7
Rio de Janeiro 7
Changsha 6
Hefei 6
Jinan 6
Shanghai 6
Shenyang 6
Falls Church 5
Istanbul 5
Milan 5
Stockholm 5
Alassio 4
Hebei 4
Johannesburg 4
Kharkiv 4
Kilburn 4
Kunming 4
Moscow 4
Ningbo 4
Porto Alegre 4
San Francisco 4
Zhengzhou 4
Boston 3
Campinas 3
Chennai 3
Chisinau 3
Dhaka 3
Dublin 3
Frankfurt am Main 3
Montreal 3
New Bedfont 3
Ogden 3
Phoenix 3
Prescot 3
Pune 3
Riga 3
Taizhou 3
Tappahannock 3
Tashkent 3
Venice 3
Alexandria 2
Amsterdam 2
Ankara 2
Baku 2
Belo Horizonte 2
Bishkek 2
Boydton 2
Brasília 2
Camden 2
Campina Grande 2
Canoas 2
Cape Town 2
Castelló de la Plana 2
Chengdu 2
Chongqing 2
Curitiba 2
Cusano Milanino 2
Giugliano In Campania 2
Gravataí 2
Totale 3.221
Salva come PNG Salva come JPEG
Nome #
Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization 197
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients 166
BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling 159
An overview on clinical, pathological and molecular features of lung metastases from colorectal cancer 157
Immunotherapy in Gastrointestinal Cancers 151
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer 147
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 142
Immunotherapy in Gastrointestinal Cancers 140
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 137
An untreatable dyspnoea: more defendants under investigation 134
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 133
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis 132
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study 130
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)–cT3 rectal cancer 121
PD-L1 expression in gastroesophageal dysplastic lesions 119
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer 118
Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center 108
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer? 101
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis 97
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives 96
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 92
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis 91
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial 88
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab 83
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study 78
Lymph node ratio is a powerful prognostic factor in patients receiving preoperative chemoradiotherapy for rectal cancer. 74
Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM) 73
Modulation of preoperative chemoradiation can reduce the requirement for abdomino-perineal resection in low rectal cancer patients 71
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study 69
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 68
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer 64
Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches 63
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 56
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling 54
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 54
Negative Ultraselection of Patients with RAS / BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy 54
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 53
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 52
BRAF-mutated colorectal adenocarcinomas: pathological heterogeneity and clinical implications 52
Multimodal treatment of radiation-induced esophageal cancer: Results of a case-matched comparative study from a single center 52
Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter 51
Mismatch repair status and gastro-oesophageal dysplasia: need for a dedicated gastrointestinal pathologist? 49
Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma 47
Proposta di PDTA per i pazienti affetti da tumore del pancreas 45
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study 41
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? 40
Ramucirumab: the long and winding road toward being an option for mCRC treatment 34
Platinum sensitivity in patients with IDH1/2 mutated versus wild-type intrahepatic cholangiocarcinoma: a propensity score-based study 28
HER2-CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients' Survival in HER2-Positive Metastatic Gastric Adenocarcinoma 24
To resect or not to resect?-the dilemma in oligometastatic breast cancer 21
null 15
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 15
Totale 4.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.696
article - articoli 20.957
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 23 120 18 32 10 51 17 63 51 59 38 20
2021/2022530 25 60 46 32 30 25 54 38 48 13 36 123
2022/2023586 87 77 11 90 76 64 12 48 75 10 29 7
2023/2024322 10 60 35 19 20 52 42 3 13 13 27 28
2024/20251.466 3 117 51 56 149 60 44 147 130 93 213 403
2025/202671 71 0 0 0 0 0 0 0 0 0 0 0
Totale 4.436